Balyasny Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-684,585
| Closed | -$8.33M | – | 1392 |
|
|
2016
Q1 | $8.33M | Buy |
684,585
+644,854
| +1,623% | +$7.85M | 0.05% | 345 |
|
|
2015
Q4 | $632K | Buy |
+39,731
| New | +$632K | ﹤0.01% | 649 |
|
|
2015
Q3 | – | Sell |
-17,290
| Closed | -$420K | – | 1333 |
|
|
2015
Q2 | $420K | Sell |
17,290
-21,310
| -55% | -$518K | ﹤0.01% | 656 |
|
|
2015
Q1 | $897K | Buy |
+38,600
| New | +$897K | 0.01% | 475 |
|
|
2013
Q4 | – | Sell |
-468,109
| Closed | -$9.55M | – | 597 |
|
|
2013
Q3 | $9.55M | Buy |
468,109
+16,739
| +4% | +$341K | 0.13% | 195 |
|
|
2013
Q2 | $9.47M | Buy |
+451,370
| New | +$9.47M | 0.16% | 122 |
|